Showing results (181-190 of 390) with videos related to

Sort By:
Pageof 39
Epilepsy & Behavior : E&B|June 21, 2019
Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsyRoy C Martin, Tyler E Gaston, Matthew Thompson, et al.
Annals of the New York Academy of Sciences|June 24, 2008
Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisoneJohn Newsom-Davis, Gary Cutter, Gil I Wolfe, et al.
Movement Disorders Clinical Practice|September 20, 2017
Effects of subthalamic nucleus deep brain stimulation on objective sleep outcomes in Parkinson's diseaseAmy W Amara, Harrison C Walker, Allen Joop, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2014
A systematic review of the incidence and prevalence of cancer in multiple sclerosisRuth Ann Marrie, Nadia Reider, Jeffrey Cohen, et al.
Annals of Clinical and Translational Neurology|February 28, 2023
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)Itay Lotan, Gabriela Romanow, Rebecca Salky, et al.
Frontiers in Neurology|July 11, 2022
The Potential for EBV Vaccines to Prevent Multiple SclerosisPeter A Maple, Alberto Ascherio, Jeffrey I Cohen, et al.
Frontiers in Neurology|July 5, 2022
Transcallosal and Corticospinal White Matter Disease and Its Association With Motor Impairment in Multiple SclerosisKeejin Yoon, Derek B Archer, Margareta A Clarke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2011
Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosisFlavia Nelson, Sushmita Datta, Nereyda Garcia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 22, 2025
Seeking optimal repeated fluid biomarker assessments to enhance precision and statistical power in clinical trials: SLIM methodHiroko H Dodge, Liu Chen, Chao-Yi Wu, et al.
Therapeutic Advances in Neurological Disorders|July 15, 2021
A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimodAmber Salter, Samantha Lancia, Gary Cutter, et al.
Pageof 39